GlassScriptPhysician profile
Brooke M Dix
NPI 1790030393
$790.74
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $342 · 2021: $118 · 2022: $214.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $539.23 | 2020-2022 | |
| Horizon Therapeutics Plc | $60.71 | 2020-2021 | |
| Dynasplint Systems INC. | $46.67 | 2019 | |
| Arthrosurface Incorporated | $29.12 | 2019 | |
| Medline Industries LP | $28.60 | 2019 | |
| Abbvie INC. | $28.39 | 2021 | |
| Smith+Nephew, INC. | $18.26 | 2020 | |
| Nabriva Therapeutics, Plc | $14.91 | 2021 | |
| Organogenesis INC. | $12.71 | 2022 | |
| Zyla Life Sciences, INC. | $12.14 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Dix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.